cerebral malaria
Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria.
21
Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis.
17
Modulation of cerebral malaria by curcumin as an adjunctive therapy
13
Cytokine response during non-cerebral and cerebral malaria: evidence of a failure to control inflammation as a cause of death in African adults
20
Uncovering the role of IFNAR1 in Experimental Cerebral malaria
162
Phosphatidylinositol 3-Kinase γ is required for the development of experimental cerebral malaria.
13
Neurological sequelae in pediatric cerebral malaria: The Indian perspective
1
Plant Hormone Salicylic Acid Produced by a Malaria Parasite Controls Host Immunity and Cerebral Malaria Outcome.
18
Specific depletion of Ly6C(hi) inflammatory monocytes prevents immunopathology in experimental cerebral malaria.
22
Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria.
12
CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo.
14
Hyperbaric Oxygen Prevents Early Death Caused by Experimental Cerebral Malaria
10
Carbon monoxide and brain sequestration of Plasmodium berghei ANKA in experimental cerebral malaria
89
A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria.
12
Vascular dysfunction as a target for adjuvant therapy in cerebral malaria
12
J. Pediatr. (Rio J.) vol.91 número6
3
Plasmodium berghei ANKA infection induces thymocyte apoptosis and thymocyte depletion in CBA mice
6
The role of animal models for research on severe malaria.
9
Arq. NeuroPsiquiatr. vol.50 número1
7
Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy.
15